Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Laitai Pharmaceutical is a comprehensive pharmaceutical enterprise based in Guangzhou, China, specializing in the research, development, and manufacturing of chemical drugs and Traditional Chinese Medicines (TCM). Established in 1998, the company is widely recognized for its "Laitai" brand, particularly its respiratory and anti-infective product lines such as the Keganmin cold relief series. The company operates a large-scale, GMP-certified manufacturing base in the Guangzhou Economic and Technological Development District, producing various dosage forms including tablets, capsules, and granules. Laitai focuses on the domestic Chinese market, providing high-quality and accessible treatments for common ailments in both adults and children. Its portfolio spans across anti-virals, antibiotics, and specialized pediatric formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 广州莱泰制药.